Slide 1: Q2 2026 Results
Q2 2026 Results Mission-critical software Predictable business Oslo, 27 August 2026
Slide 2: The second quarter 2026 numbers in a nutshell
The second quarter 2026 numbers in a nutshell Emergency 44% 56% Specialised Healthcare Income 127 MNOK EBITDA Margin 25% Organic Growth Q/Q 9% Income 55 MNOK Income 71 MNOK EBITDA Margin 22% EBITDA Margin 28% Organic Growth Q/Q 7% Organic Growth Q/Q 10% The Specialised Healthcare business was establ
Slide 3: Specialised healthcare
Specialised healthcare Woman & Child Medication Management Omda supports specialised healthcare value chains through an ecosystem of different software solutions Connected Imaging LIMS – Blood Management Health Analytics 3
Slide 4: The Emergency value chain strengthened with PSS
The Emergency value chain strengthened with PSS Planning & Preparedness Analysis & Improvement Omda supports every step of emergency response through an ecosystem of different software solutions Calls & Dispatch On Scene Response Transport and Care Hospital Care 4
Slide 5: The UK is becoming a key market
The UK is becoming a key market UK annual sales1) 15% Moldova 1 Croatia 2 Montenegro 2% 5 1) Including Saab PSS business
Slide 6: Second quarter 2026 performance
Second quarter 2026 performance Reported revenue Organic growth Y/Y 127 MNOK 9% 6
Slide 7: Profitable organic development
Profitable organic development Reported EBITDA Reported EBITDA margin 32 MNOK 25% 7
Slide 8: Revenue quality supports predictability
Revenue quality supports predictability Recurring SW-revenue SW-Recurring share 97 MNOK 76% Professional Services 25 MNOK, ~90% recurring 8
Slide 9: Predictability is built into the customer model
Predictability is built into the customer model Embedded by design Reliable by relation • Mission-critical daily workflows • Long customer relationships • Certified and deeply integrated • Repeatable profitable organic products development • Public-sector customer base • Recurring revenues • High co
Slide 10: Current Pro Forma Growth Outlook 2026-2027
Current Pro Forma Growth Outlook 2026-2027 800 700 Acquired business 600 500 400 EBITDA 300 EBITDA Organic business 28-32% 28-32% 200 100 0 2026 2027 10
Slide 11: Guidance and growth ambitions (Proforma)
Guidance and growth ambitions (Proforma1)) 1400 Growth ambitions 1200 1000 800 Actuals Guidance 600 400 200 0 2025 2026 2027 2028 2029 2030 Revenue Base Acquired Revenue 1) 2025 is base. Constant currency. 5% organic growth and 15% acquired growth. 11
Slide 12: Saab PSS sharpens the Emergency business
Saab PSS sharpens the Emergency business • Expands Omda’s footprint in the UK public sector • Strengthens the offering across the emergency value chain • Adds around 75 employees • Expected closing Q4 2026 • Recent proof point: – Additional contracts with customers: 60 MSEK… – … an estimated annual r
Slide 13: AI strengthens productivity
AI strengthens productivity • Omda delivers certified software for mission-critical workflows • AI supports development, testing, documentation and service productivity • Q2 observation: Slightly lower capex • Long-term ambition: lower capitalised development as a share of revenue 13
Slide 14: Capital allocation: lower cost, greater capacity
Capital allocation: lower cost, greater capacity • Exploring refinancing of the bond (OMDA-02 PRO) • Objective: – Lower interest cost and increase strategic capacity • Investment remains focused on – Targeted acquisitions – Add-ons to customers – AI-enabled productivity • Disciplined Build vs Buy bu
Slide 15: The long-term Omda model
The long-term Omda model • Organic growth 5–10% • Acquired growth 10–20% per year • EBITDA above 30% over time • Capitalised development from approximately 10% towards 5% of revenue • Portfolio centred on Emergency and Specialised Healthcare • Growth funded through cash flow and disciplined leverage
Slide 16: The trend is as important as the Q2 2026 predictability
The trend is as important as the Q2 2026 predictability 30% 25% 20% 15% 10% 5% 0% Q2-24 Q2-25 Q2-26 EBITDA Margin EBITDAC Margin 16
Slide 17: What Q2 adds to the Omda story
What Q2 adds to the Omda story • Predictable and profitable organic development • The transformational Saab PSS acquisition was signed • A clearer portfolio centred on two principal markets • AI and disciplined product investment support scalable growth • 2026 guidance and long-term ambitions reiter
Slide 18: The way forward
The way forward 18
Slide 19: Q&A
Q&A Omda